Gut Microbiota: A Potential Target for Cancer Interventions

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.2166033538338
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Daillere R, Roberti MP, et al. Anticancer effects of the microbiome and its products. Nat Rev Microbiol. 2017;15(8):465–478. doi:10.1038/nrmicro.2017.4428529325
   PubMed Web of Science ®Google Scholar
• Dzutsev A, Badger JH, Perez-Chanona E, et al. Microbes and Cancer. Annu Rev Immunol. 2017;35:199–228. doi:10.1146/annurev-immunol-051116-05213328142322
   PubMed Web of Science ®Google Scholar
• Yu D, Yu X, Ye A, et al. Profiling of gut microbial dysbiosis in adults with myeloid leukemia. FEBS Open Bio. 2021;11(7):2050–2059. doi:10.1002/2211-5463.13193
   PubMed Web of Science ®Google Scholar
• Xie YH, Gao QY, Cai GX, et al. Fecal clostridium symbiosum for noninvasive detection of early and advanced colorectal cancer: test and validation studies. EBioMedicine. 2017;25:32–40. doi:10.1016/j.ebiom.2017.10.00529033369
   PubMed Web of Science ®Google Scholar
• Roy S, Trinchieri G. Microbiota: a key orchestrator of cancer therapy. Nat Rev Cancer. 2017;17(5):271–285. doi:10.1038/nrc.2017.1328303904
   PubMed Web of Science ®Google Scholar
• Garrett WS. Cancer and the microbiota. Science. 2015;348(6230):80–86. doi:10.1126/science.aaa497225838377
   PubMed Web of Science ®Google Scholar
• Helmink BA, Khan MAW, Hermann A, et al. The microbiome, cancer, and cancer therapy. Nat Med. 2019;25(3):377–388. doi:10.1038/s41591-019-0377-730842679
   PubMed Web of Science ®Google Scholar
• Gopalakrishnan V, Helmink BA, Spencer CN, et al. The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy. Cancer Cell. 2018;33(4):570–580. doi:10.1016/j.ccell.2018.03.01529634945
   PubMed Web of Science ®Google Scholar
• Rossi P, Difrancia R, Quagliariello V, et al. B-glucans from Grifola frondosa and Ganoderma lucidum in breast cancer: an example of complementary and integrative medicine. Oncotarget. 2018;9(37):24837–24856. doi:10.18632/oncotarget.2498429872510
   PubMedGoogle Scholar
• Rodriguez JM, Murphy K, Stanton C, et al. The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health Dis. 2015;26:26050.25651996
   PubMed Web of Science ®Google Scholar
• Tropini C, Earle KA, Huang KC, et al. The gut microbiome: connecting spatial organization to function. Cell Host Microbe. 2017;21(4):433–442. doi:10.1016/j.chom.2017.03.01028407481
   PubMed Web of Science ®Google Scholar
• Friedman ES, Bittinger K, Esipova TV, et al. Microbes vs. chemistry in the origin of the anaerobic gut lumen. Proc Natl Acad Sci U S A. 2018;115(16):4170–4175. doi:10.1073/pnas.171863511529610310
   PubMed Web of Science ®Google Scholar
• Martinez-Guryn K, Leone V, Chang EB. Regional diversity of the gastrointestinal microbiome. Cell Host Microbe. 2019;26(3):314–324. doi:10.1016/j.chom.2019.08.01131513770
   PubMed Web of Science ®Google Scholar
• Allegra A, Musolino C, Tonacci A, et al. Interactions between the MicroRNAs and Microbiota in Cancer Development: roles and Therapeutic Opportunities. Cancers. 2020;12(4):805. doi:10.3390/cancers12040805
   PubMed Web of Science ®Google Scholar
• Lu K, Mahbub R, Fox JG. Xenobiotics: interaction with the Intestinal Microflora. ILAR J. 2015;56(2):218–227. doi:10.1093/ilar/ilv01826323631
   PubMed Web of Science ®Google Scholar
• Chen P, Chen X, Hao L, et al. The bioavailability of soybean polysaccharides and their metabolites on gut microbiota in the simulator of the human intestinal microbial ecosystem (SHIME). Food Chem. 2021;362:130233. doi:10.1016/j.foodchem.2021.13023334090043
   PubMed Web of Science ®Google Scholar
• van der Hee B, Wells JM. Microbial regulation of host physiology by short-chain fatty acids. Trends Microbiol. 2021;29(8):700–712. doi:10.1016/j.tim.2021.02.00133674141
   PubMed Web of Science ®Google Scholar
• Bozzi Cionci N, Baffoni L, Gaggia F, et al. Therapeutic microbiology: the role of bifidobacterium breve as food supplement for the prevention/treatment of paediatric diseases. Nutrients. 2018;10(11):1723. doi:10.3390/nu10111723
   PubMed Web of Science ®Google Scholar
• Fragkou PC, Karaviti D, Zemlin M, et al. Impact of early life nutrition on children’s immune system and noncommunicable diseases through its effects on the bacterial microbiome, virome and mycobiome. Front Immunol. 2021;12:644269. doi:10.3389/fimmu.2021.64426933815397
   PubMed Web of Science ®Google Scholar
• Zhao Y, Liu Y, Li S, et al. Role of lung and gut microbiota on lung cancer pathogenesis. J Cancer Res Clin Oncol. 2021;147(8):2177–2186. doi:10.1007/s00432-021-03644-034018055
   PubMed Web of Science ®Google Scholar
• Kim D, Zeng MY, Nunez G. The interplay between host immune cells and gut microbiota in chronic inflammatory diseases. Exp Mol Med. 2017;49(5):e339. doi:10.1038/emm.2017.2428546562
   PubMed Web of Science ®Google Scholar
• Ogbonnaya ES, Clarke G, Shanahan F, et al. Adult hippocampal neurogenesis is regulated by the microbiome. Biol Psychiatry. 2015;78(4):e7–e9. doi:10.1016/j.biopsych.2014.12.02325700599
   PubMed Web of Science ®Google Scholar
• Codagnone MG, Stanton C, O’Mahony SM, et al. Microbiota and Neurodevelopmental trajectories: role of maternal and early-life nutrition. Ann Nutr Metab. 2019;74(Suppl 2):16–27. doi:10.1159/00049914431234188
   PubMed Web of Science ®Google Scholar
• Strandwitz P. Neurotransmitter modulation by the gut microbiota. Brain Res. 2018;1693(Pt B):128–133. doi:10.1016/j.brainres.2018.03.01529903615
   PubMed Web of Science ®Google Scholar
• Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017;19(1):29–41. doi:10.1111/1462-2920.1358927928878
   PubMed Web of Science ®Google Scholar
• Paul B, Barnes S, Demark-Wahnefried W, et al. Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases. Clin Epigenetics. 2015;7:112. doi:10.1186/s13148-015-0144-726478753
   PubMed Web of Science ®Google Scholar
• Sampsell K, Hao D, Reimer RA. The gut microbiota: a potential gateway to improved health outcomes in breast cancer treatment and survivorship. Int J Mol Sci. 2020;21(23):9239. doi:10.3390/ijms21239239
   PubMed Web of Science ®Google Scholar
• Pugin B, Barcik W, Westermann P, et al. A wide diversity of bacteria from the human gut produces and degrades biogenic amines. Microb Ecol Health Dis. 2017;28(1):1353881.28959180
   PubMedGoogle Scholar
• Magnúsdóttir S, Ravcheev D, de Crécy-lagard V, et al. Systematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes. Front Genet. 2015;6:148. doi:10.3389/fgene.2015.0014825941533
   PubMed Web of Science ®Google Scholar
• Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer. 2013;13(11):800–812. doi:10.1038/nrc361024132111
   PubMed Web of Science ®Google Scholar
• Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219–232. doi:10.1038/nri.2017.728260787
   PubMed Web of Science ®Google Scholar
• Parida S, Sharma D. The microbiome and cancer: creating friendly neighborhoods and removing the foes within. Cancer Res. 2021;81(4):790–800. doi:10.1158/0008-5472.CAN-20-262933148661
   PubMed Web of Science ®Google Scholar
• Vivarelli S, Salemi R, Candido S, et al. Gut microbiota and cancer: from pathogenesis to therapy. Cancers. 2019;11(1):38. doi:10.3390/cancers11010038
   PubMed Web of Science ®Google Scholar
• Khan FH, Bhat BA, Sheikh BA, et al. Microbiome dysbiosis and epigenetic modulations in lung cancer: from pathogenesis to therapy. Semin Cancer Biol. 2021. doi:10.1016/j.semcancer.2021.07.005
   Web of Science ®Google Scholar
• Villeger R, Lopes A, Veziant J, et al. Microbial markers in colorectal cancer detection and/or prognosis. World J Gastroenterol. 2018;24(22):2327–2347. doi:10.3748/wjg.v24.i22.232729904241
   PubMed Web of Science ®Google Scholar
• Amieva M, Peek RM Jr. Pathobiology of helicobacter pylori-induced gastric cancer. Gastroenterology. 2016;150(1):64–78. doi:10.1053/j.gastro.2015.09.00426385073
   PubMed Web of Science ®Google Scholar
• Yu T, Guo F, Yu Y, et al. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell. 2017;170(3):548–563 e516. doi:10.1016/j.cell.2017.07.00828753429
   PubMed Web of Science ®Google Scholar
• Feng J, Zhao F, Sun J, et al. Alterations in the gut microbiota and metabolite profiles of thyroid carcinoma patients. Int J Cancer. 2019;144(11):2728–2745. doi:10.1002/ijc.3200730565661
   PubMed Web of Science ®Google Scholar
• Goedert JJ, Jones G, Hua X, et al. Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study. J Natl Cancer Inst. 2015;107:8. doi:10.1093/jnci/djv147
   Google Scholar
• Vernocchi P, Gili T, Conte F, et al. Network analysis of gut microbiome and metabolome to discover microbiota-linked biomarkers in patients affected by non-small cell lung cancer. Int J Mol Sci. 2020;21(22):8730. doi:10.3390/ijms21228730
   PubMed Web of Science ®Google Scholar
• Zheng Y, Fang Z, Xue Y, et al. Specific gut microbiome signature predicts the early-stage lung cancer. Gut Microbes. 2020;11(4):1030–1042. doi:10.1080/19490976.2020.173748732240032
   PubMed Web of Science ®Google Scholar
• Coker OO, Dai Z, Nie Y, et al. Mucosal microbiome dysbiosis in gastric carcinogenesis. Gut. 2018;67(6):1024–1032. doi:10.1136/gutjnl-2017-31428128765474
   PubMed Web of Science ®Google Scholar
• Hsieh YY, Tung SY, Pan HY, et al. Increased Abundance of Clostridium and Fusobacterium in Gastric Microbiota of Patients with Gastric Cancer in Taiwan. Sci Rep. 2018;8(1):158. doi:10.1038/s41598-017-18596-029317709
   PubMed Web of Science ®Google Scholar
• Ferreira RM, Pereira-Marques J, Pinto-Ribeiro I, et al. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut. 2018;67(2):226–236. doi:10.1136/gutjnl-2017-31420529102920
   PubMed Web of Science ®Google Scholar
• Zhang Y, Shen J, Shi X, et al. Gut microbiome analysis as a predictive marker for the gastric cancer patients. Appl Microbiol Biotechnol. 2021;105(2):803–814. doi:10.1007/s00253-020-11043-733404833
   PubMed Web of Science ®Google Scholar
• Pushalkar S, Hundeyin M, Daley D, et al. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov. 2018;8(4):403–416. doi:10.1158/2159-8290.CD-17-113429567829
   PubMed Web of Science ®Google Scholar
• Yang J, Li D, Yang Z, et al. Establishing high-accuracy biomarkers for colorectal cancer by comparing fecal microbiomes in patients with healthy families. Gut Microbes. 2020;11(4):918–929. doi:10.1080/19490976.2020.171298631971861
   PubMed Web of Science ®Google Scholar
• Thomas AM, Manghi P, Asnicar F, et al. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. Nat Med. 2019;25(4):667–678. doi:10.1038/s41591-019-0405-730936548
   PubMed Web of Science ®Google Scholar
• Kostic AD, Gevers D, Pedamallu CS, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012;22(2):292–298. doi:10.1101/gr.126573.11122009990
   PubMed Web of Science ®Google Scholar
• Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14(2):207–215. doi:10.1016/j.chom.2013.07.00723954159
   PubMed Web of Science ®Google Scholar
• Gagniere J, Raisch J, Veziant J, et al. Gut microbiota imbalance and colorectal cancer. World J Gastroenterol. 2016;22(2):501–518. doi:10.3748/wjg.v22.i2.50126811603
   PubMed Web of Science ®Google Scholar
• Wu N, Yang X, Zhang R, et al. Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb Ecol. 2013;66(2):462–470. doi:10.1007/s00248-013-0245-923733170
   PubMed Web of Science ®Google Scholar
• Panebianco C, Andriulli A, Pazienza V. Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies. Microbiome. 2018;6(1):92. doi:10.1186/s40168-018-0483-729789015
   PubMed Web of Science ®Google Scholar
• Whisner CM, Athena Aktipis C. The Role of the Microbiome in Cancer Initiation and Progression: how Microbes and Cancer Cells Utilize Excess Energy and Promote One Another’s Growth. Curr Nutr Rep. 2019;8(1):42–51. doi:10.1007/s13668-019-0257-230758778
   PubMedGoogle Scholar
• Ogrendik M. Periodontal pathogens in the etiology of pancreatic cancer. Gastrointest Tumors. 2017;3(3–4):125–127. doi:10.1159/00045270828611978
   PubMed Web of Science ®Google Scholar
• Wilson MR, Jiang Y, Villalta PW, et al. The human gut bacterial genotoxin colibactin alkylates DNA. Science. 2019;363:6428. doi:10.1126/science.aar7785
   Web of Science ®Google Scholar
• Scott AJ, Alexander JL, Merrifield CA, et al. International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis. Gut. 2019;68(9):1624–1632. doi:10.1136/gutjnl-2019-31855631092590
   PubMed Web of Science ®Google Scholar
• Nguyen LH, Ma W, Wang DD, et al. Association between sulfur-metabolizing bacterial communities in stool and risk of distal colorectal cancer in men. Gastroenterology. 2020;158(5):1313–1325. doi:10.1053/j.gastro.2019.12.02931972239
   PubMed Web of Science ®Google Scholar
• Andriamihaja M, Lan A, Beaumont M, et al. The deleterious metabolic and genotoxic effects of the bacterial metabolite p-cresol on colonic epithelial cells. Free Radic Biol Med. 2015;85:219–227. doi:10.1016/j.freeradbiomed.2015.04.00425881551
   PubMed Web of Science ®Google Scholar
• Tahara T, Hirata I, Nakano N, et al. Potential link between Fusobacterium enrichment and DNA methylation accumulation in the inflammatory colonic mucosa in ulcerative colitis. Oncotarget. 2017;8(37):61917–61926. doi:10.18632/oncotarget.1871628977914
   PubMedGoogle Scholar
• Afify SM, Seno M. Conversion of stem cells to cancer stem cells: undercurrent of cancer initiation. Cancers. 2019;11(3). doi:10.3390/cancers11030345
   PubMed Web of Science ®Google Scholar
• Yousefi B, Mohammadlou M, Abdollahi M, et al. Epigenetic changes in gastric cancer induction by Helicobacter pylori. J Cell Physiol. 2019;234(12):21770–21784. doi:10.1002/jcp.2892531169314
   PubMed Web of Science ®Google Scholar
• Caballero S, Pamer EG. Microbiota-mediated inflammation and antimicrobial defense in the intestine. Annu Rev Immunol. 2015;33:227–256. doi:10.1146/annurev-immunol-032713-12023825581310
   PubMed Web of Science ®Google Scholar
• Wei MY, Shi S, Liang C, et al. The microbiota and microbiome in pancreatic cancer: more influential than expected. Mol Cancer. 2019;18(1):97. doi:10.1186/s12943-019-1008-031109338
   PubMed Web of Science ®Google Scholar
• Chung L, Thiele Orberg E, Geis AL, et al. Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells. Cell Host Microbe. 2018;23(2):203–214 e205. doi:10.1016/j.chom.2018.01.00729398651
   PubMed Web of Science ®Google Scholar
• Buchta Rosean C, Bostic RR, Ferey JCM, et al. Preexisting commensal dysbiosis is a host-intrinsic regulator of tissue inflammation and tumor cell dissemination in hormone receptor-positive breast cancer. Cancer Res. 2019;79(14):3662–3675. doi:10.1158/0008-5472.CAN-18-346431064848
   PubMed Web of Science ®Google Scholar
• Rutkowski MR, Svoronos N, Perales-Puchalt A, et al. The tumor macroenvironment: cancer-promoting networks beyond tumor beds. Adv Cancer Res. 2015;128:235–262.26216635
   PubMed Web of Science ®Google Scholar
• Wong DV, Lima-Junior RC, Carvalho CB, et al. The Adaptor protein myd88 is a key signaling molecule in the pathogenesis of irinotecan-induced intestinal mucositis. PLoS One. 2015;10(10):e0139985. doi:10.1371/journal.pone.013998526440613
   PubMed Web of Science ®Google Scholar
• Albulescu R, Codrici E, Popescu ID, et al. Cytokine patterns in brain tumour progression. Mediators Inflamm. 2013;2013:979748. doi:10.1155/2013/97974823864770
   PubMed Web of Science ®Google Scholar
• Qiu Q, Lin Y, Ma Y, et al. Exploring the emerging role of the gut microbiota and tumor microenvironment in cancer immunotherapy. Front Immunol. 2020;11:612202. doi:10.3389/fimmu.2020.61220233488618
   PubMed Web of Science ®Google Scholar
• Ducimetiere L, Vermeer M, Tugues S. The Interplay Between Innate Lymphoid Cells and the Tumor Microenvironment. Front Immunol. 2019;10:2895. doi:10.3389/fimmu.2019.0289531921156
   PubMed Web of Science ®Google Scholar
• Gur C, Ibrahim Y, Isaacson B, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity. 2015;42(2):344–355. doi:10.1016/j.immuni.2015.01.01025680274
   PubMed Web of Science ®Google Scholar
• Gur C, Maalouf N, Shhadeh A, et al. Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1. Oncoimmunology. 2019;8(6):e1581531. doi:10.1080/2162402X.2019.158153131069151
   PubMed Web of Science ®Google Scholar
• Rubinstein MR, Baik JE, Lagana SM, et al. Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/beta-catenin modulator Annexin A1. EMBO Rep. 2019;20(4). doi:10.15252/embr.201847638
   PubMed Web of Science ®Google Scholar
• Zhang Q, Ma C, Duan Y, et al. Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma. Cancer Discov. 2021;11(5):1248–1267. doi:10.1158/2159-8290.CD-20-030433323397
   PubMed Web of Science ®Google Scholar
• Pandey S, Singh S, Anang V, et al. Pattern recognition receptors in cancer progression and metastasis. Cancer Growth Metastasis. 2015;8:25–34. doi:10.4137/CGM.S2431426279628
   PubMedGoogle Scholar
• Seifert L, Werba G, Tiwari S, et al. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature. 2016;532(7598):245–249. doi:10.1038/nature1740327049944
   PubMed Web of Science ®Google Scholar
• Zambirinis CP, Levie E, Nguy S, et al. TLR9 ligation in pancreatic stellate cells promotes tumorigenesis. J Exp Med. 2015;212(12):2077–2094. doi:10.1084/jem.2014216226481685
   PubMed Web of Science ®Google Scholar
• Sun J, Chang EB. Exploring gut microbes in human health and disease: pushing the envelope. Genes Dis. 2014;1(2):132–139. doi:10.1016/j.gendis.2014.08.00125642449
   PubMedGoogle Scholar
• Deng L, Wang R, Li H, et al. miRNA-Gene Regulatory Network in Gnotobiotic Mice Stimulated by Dysbiotic Gut Microbiota Transplanted From a Genetically Obese Child. Front Microbiol. 2019;10:1517. doi:10.3389/fmicb.2019.0151731333621
   PubMed Web of Science ®Google Scholar
• Hoban AE, Stilling RM. Microbial regulation of microRNA expression in the amygdala and prefrontal cortex. Microbiome. 2017;5(1):102. doi:10.1186/s40168-017-0321-328838324
   PubMed Web of Science ®Google Scholar
• Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014;12(10):661–672. doi:10.1038/nrmicro334425198138
   PubMed Web of Science ®Google Scholar
• Ha CW, Lam YY, Holmes AJ. Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health. World J Gastroenterol. 2014;20(44):16498–16517. doi:10.3748/wjg.v20.i44.1649825469018
   PubMed Web of Science ®Google Scholar
• Wang T, Cai G, Qiu Y, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 2012;6(2):320–329. doi:10.1038/ismej.2011.10921850056
   PubMed Web of Science ®Google Scholar
• Farhana L, Nangia-Makker P, Arbit E, et al. Bile acid: a potential inducer of colon cancer stem cells. Stem Cell Res Ther. 2016;7(1):181. doi:10.1186/s13287-016-0439-427908290
   PubMed Web of Science ®Google Scholar
• Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013;341(6145):569–573. doi:10.1126/science.124116523828891
   PubMed Web of Science ®Google Scholar
• Lee JV, Berry CT, Kim K, et al. Acetyl-CoA promotes glioblastoma cell adhesion and migration through Ca(2+)-NFAT signaling. Genes Dev. 2018;32(7–8):497–511. doi:10.1101/gad.311027.11729674394
   PubMed Web of Science ®Google Scholar
• Lu M, Zhu WW, Wang X, et al. ACOT12-Dependent Alteration of Acetyl-CoA Drives Hepatocellular Carcinoma Metastasis by Epigenetic Induction of Epithelial-Mesenchymal Transition. Cell Metab. 2019;29(4):886–900 e885. doi:10.1016/j.cmet.2018.12.01930661930
   PubMed Web of Science ®Google Scholar
• Schug ZT, Peck B, Jones DT, et al. Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell. 2015;27(1):57–71. doi:10.1016/j.ccell.2014.12.00225584894
   PubMed Web of Science ®Google Scholar
• Wallace JL, Blackler RW, Chan MV, et al. Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics. Antioxid Redox Signal. 2015;22(5):398–410. doi:10.1089/ars.2014.590124635322
   PubMed Web of Science ®Google Scholar
• Saint-Georges-Chaumet Y, Edeas M. Microbiota-mitochondria inter-talk: consequence for microbiota-host interaction. Pathog Dis. 2016;74(1):ftv096. doi:10.1093/femspd/ftv09626500226
   PubMed Web of Science ®Google Scholar
• Ijssennagger N, van der Meer R, van Mil SWC. Sulfide as a Mucus Barrier-Breaker in Inflammatory Bowel Disease? Trends Mol Med. 2016;22(3):190–199. doi:10.1016/j.molmed.2016.01.00226852376
   PubMed Web of Science ®Google Scholar
• Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68(4):250–281. doi:10.3322/caac.2145729846947
   PubMed Web of Science ®Google Scholar
• Wu Y, Jiao N, Zhu R, et al. Identification of microbial markers across populations in early detection of colorectal cancer. Nat Commun. 2021;12(1):3063. doi:10.1038/s41467-021-23265-y34031391
   PubMed Web of Science ®Google Scholar
• Luu TH, Michel C, Bard JM, et al. Intestinal Proportion of Blautia sp. is Associated with Clinical Stage and Histoprognostic Grade in Patients with Early-Stage Breast Cancer. Nutr Cancer. 2017;69(2):267–275. doi:10.1080/01635581.2017.126375028094541
   PubMed Web of Science ®Google Scholar
• Jia X, Lu S, Zeng Z, et al. Characterization of Gut Microbiota, Bile Acid Metabolism, and Cytokines in Intrahepatic Cholangiocarcinoma. Hepatology. 2020;71(3):893–906. doi:10.1002/hep.3085231298745
   PubMed Web of Science ®Google Scholar
• Haghi F, Goli E, Mirzaei B, et al. The association between fecal enterotoxigenic B. fragilis with colorectal cancer. BMC Cancer. 2019;19(1):879. doi:10.1186/s12885-019-6115-131488085
   PubMed Web of Science ®Google Scholar
• Lowenmark T, Lofgren-Burstrom A, Zingmark C, et al. Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancer. Sci Rep. 2020;10(1):15250. doi:10.1038/s41598-020-72132-132943695
   PubMed Web of Science ®Google Scholar
• Khan DA. Proactive management of penicillin and other antibiotic allergies. Allergy Asthma Proc. 2020;41(2):82–89. doi:10.2500/aap.2020.41.19002432122444
   PubMed Web of Science ®Google Scholar
• Iqbal U, Anwar H, Karim MA. Safety and efficacy of encapsulated fecal microbiota transplantation for recurrent Clostridium difficile infection: a systematic review. Eur J Gastroenterol Hepatol. 2018;30(7):730–734. doi:10.1097/MEG.000000000000114729688901
   PubMed Web of Science ®Google Scholar
• Babjuk M, Burger M, Comperat EM, et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. Eur Urol. 2019;76(5):639–657. doi:10.1016/j.eururo.2019.08.01631443960
   PubMed Web of Science ®Google Scholar
• Alexander JL, Wilson ID, Teare J, et al. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol. 2017;14(6):356–365. doi:10.1038/nrgastro.2017.2028270698
   PubMed Web of Science ®Google Scholar
• Daillere R, Vetizou M, Waldschmitt N, et al. Enterococcus hirae and barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects. Immunity. 2016;45(4):931–943. doi:10.1016/j.immuni.2016.09.00927717798
   PubMed Web of Science ®Google Scholar
• Viaud S, Saccheri F, Mignot G, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 2013;342(6161):971–976. doi:10.1126/science.124053724264990
   PubMed Web of Science ®Google Scholar
• Iida N, Dzutsev A, Stewart CA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013;342(6161):967–970. doi:10.1126/science.124052724264989
   PubMed Web of Science ®Google Scholar
• Shen S, Lim G, You Z, et al. Gut microbiota is critical for the induction of chemotherapy-induced pain. Nat Neurosci. 2017;20(9):1213–1216. doi:10.1038/nn.460628714953
   PubMed Web of Science ®Google Scholar
• Ding C, Tang W, Fan X, et al. Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics. Onco Targets Ther. 2018;11:4797–4810. doi:10.2147/OTT.S17062630147331
   PubMed Web of Science ®Google Scholar
• Yan A, Culp E, Perry J, et al. Transformation of the anticancer drug doxorubicin in the human gut microbiome. ACS Infect Dis. 2018;4(1):68–76. doi:10.1021/acsinfecdis.7b0016629160065
   PubMed Web of Science ®Google Scholar
• Geller LT, Barzily-Rokni M, Danino T, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357(6356):1156–1160. doi:10.1126/science.aah504328912244
   PubMed Web of Science ®Google Scholar
• Uribe-Herranz M, Rafail S, Beghi S, et al. Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response. J Clin Invest. 2020;130(1):466–479. doi:10.1172/JCI12433231815742
   PubMed Web of Science ®Google Scholar
• Alexeev EE, Lanis JM, Kao DJ, et al. Microbiota-Derived Indole Metabolites Promote Human and Murine Intestinal Homeostasis through Regulation of Interleukin-10 Receptor. Am J Pathol. 2018;188(5):1183–1194. doi:10.1016/j.ajpath.2018.01.01129454749
   PubMed Web of Science ®Google Scholar
• Xiao HW, Cui M, Li Y, et al. Gut microbiota-derived indole 3-propionic acid protects against radiation toxicity via retaining acyl-CoA-binding protein. Microbiome. 2020;8(1):69. doi:10.1186/s40168-020-00845-632434586
   PubMed Web of Science ®Google Scholar
• Reis Ferreira M, Andreyev HJN, Mohammed K, et al. Microbiota- and Radiotherapy-Induced Gastrointestinal Side-Effects (Mars) Study: a Large Pilot Study of the Microbiome in Acute and Late-Radiation Enteropathy. Clin Cancer Res. 2019;25(21):6487–6500. doi:10.1158/1078-0432.CCR-19-096031345839
   PubMed Web of Science ®Google Scholar
• Kennedy LB, Salama AKS. A review of cancer immunotherapy toxicity. CA Cancer J Clin. 2020;70(2):86–104. doi:10.3322/caac.2159631944278
   PubMed Web of Science ®Google Scholar
• Vétizou M, Pitt JM, Daillère R, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015;350(6264):1079–1084. doi:10.1126/science.aad132926541610
   PubMed Web of Science ®Google Scholar
• Sivan A, Corrales L, Hubert N, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015;350(6264):1084–1089. doi:10.1126/science.aac425526541606
   PubMed Web of Science ®Google Scholar
• Gopalakrishnan V, Spencer CN, Nezi L, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018;359(6371):97–103. doi:10.1126/science.aan423629097493
   PubMed Web of Science ®Google Scholar
• Derosa L, Hellmann MD, Spaziano M, et al. Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer. Ann Oncol. 2018;29(6):1437–1444. doi:10.1093/annonc/mdy10329617710
   PubMed Web of Science ®Google Scholar
• Routy B, Le Chatelier E, Derosa L, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359(6371):91–97. doi:10.1126/science.aan370629097494
   PubMed Web of Science ®Google Scholar
• Frankel AE, Coughlin LA, Kim J, et al. Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients. Neoplasia. 2017;19(10):848–855. doi:10.1016/j.neo.2017.08.00428923537
   PubMed Web of Science ®Google Scholar
• Temraz S, Nassar F, Nasr R, et al. Gut Microbiome: a Promising Biomarker for Immunotherapy in Colorectal Cancer. Int J Mol Sci. 2019;20:17. doi:10.3390/ijms20174155
   Web of Science ®Google Scholar
• So D, Whelan K, Rossi M, et al. Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis. Am J Clin Nutr. 2018;107(6):965–983. doi:10.1093/ajcn/nqy04129757343
   PubMed Web of Science ®Google Scholar
• Mendez Utz VE, Perez Visnuk D, Perdigon G, et al. Milk fermented by Lactobacillus casei CRL431 administered as an immune adjuvant in models of breast cancer and metastasis under chemotherapy. Appl Microbiol Biotechnol. 2021;105(1):327–340. doi:10.1007/s00253-020-11007-x33205285
   PubMed Web of Science ®Google Scholar
• Bhatt AP, Redinbo MR, Bultman SJ. The role of the microbiome in cancer development and therapy. CA Cancer J Clin. 2017;67(4):326–344. doi:10.3322/caac.2139828481406
   PubMed Web of Science ®Google Scholar
• Taherian M, Mahin Samadi P, Rastegar H, et al. An Overview on Probiotics as an Alternative Strategy for Prevention and Treatment of Human Diseases. Iran J Pharm Res. 2019;18(Suppl1):31–50.32802088
   PubMed Web of Science ®Google Scholar
• Al-Sadi R, Nighot P, Nighot M, et al. Lactobacillus acidophilus Induces a Strain-specific and Toll-Like Receptor 2-Dependent Enhancement of Intestinal Epithelial Tight Junction Barrier and Protection Against Intestinal Inflammation. Am J Pathol. 2021;191(5):872–884. doi:10.1016/j.ajpath.2021.02.00333607043
   PubMed Web of Science ®Google Scholar
• Al-Sadi R, Dharmaprakash V, Nighot P, et al. Bifidobacterium bifidum Enhances the Intestinal Epithelial Tight Junction Barrier and Protects against Intestinal Inflammation by Targeting the Toll-like Receptor-2 Pathway in an NF-kappaB-Independent Manner. Int J Mol Sci. 2021;22:15. doi:10.3390/ijms22158070
   Web of Science ®Google Scholar
• Asadollahi P, Ghanavati R, Rohani M, et al. Anti-cancer effects of Bifidobacterium species in colon cancer cells and a mouse model of carcinogenesis. PLoS One. 2020;15(5):e0232930. doi:10.1371/journal.pone.023293032401801
   PubMed Web of Science ®Google Scholar
• Chou YC, Ho PY, Chen WJ, et al. Lactobacillus fermentum V3 ameliorates colitis-associated tumorigenesis by modulating the gut microbiome. Am J Cancer Res. 2020;10(4):1170–1181.32368393
   PubMed Web of Science ®Google Scholar
• Chung Y, Ryu Y, An BC, et al. A synthetic probiotic engineered for colorectal cancer therapy modulates gut microbiota. Microbiome. 2021;9(1):122. doi:10.1186/s40168-021-01071-434039418
   PubMed Web of Science ®Google Scholar
• Ghidini M, Nicoletti M, Ratti M, et al. Lactobacillus Kefiri LKF01 (Kefibios((R))) for Prevention of Diarrhoea in Cancer Patients Treated with Chemotherapy: a Prospective Study. Nutrients. 2021;13(2):385. doi:10.3390/nu1302038533513713
   PubMed Web of Science ®Google Scholar
• Gibson GR, Hutkins R, Sanders ME, et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14(8):491–502. doi:10.1038/nrgastro.2017.7528611480
   PubMed Web of Science ®Google Scholar
• Li Y, Elmen L, Segota I, et al. Prebiotic-Induced Anti-tumor Immunity Attenuates Tumor Growth. Cell Rep. 2020;30(6):1753–1766 e1756. doi:10.1016/j.celrep.2020.01.03532049008
   PubMed Web of Science ®Google Scholar
• Bressa C, Bailen-Andrino M, Perez-Santiago J, et al. Differences in gut microbiota profile between women with active lifestyle and sedentary women. PLoS One. 2017;12(2):e0171352. doi:10.1371/journal.pone.017135228187199
   PubMed Web of Science ®Google Scholar
• McKenney PT, Pamer EG. From Hype to Hope: the Gut Microbiota in Enteric Infectious Disease. Cell. 2015;163(6):1326–1332. doi:10.1016/j.cell.2015.11.03226638069
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Surette MG, Kim PT, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015;149(1):102–109 e106. doi:10.1053/j.gastro.2015.04.00125857665
   PubMed Web of Science ®Google Scholar
• Navalkele BD, Polistico J, Sandhu A, et al. Clinical outcomes after faecal microbiota transplant by retention enema in both immunocompetent and immunocompromised patients with recurrent Clostridioides difficile infections at an academic medical centre. J Hosp Infect. 2020;106(4):643–648. doi:10.1016/j.jhin.2020.09.02732991940
   PubMed Web of Science ®Google Scholar
• Innes AJ, Mullish BH, Fernando F, et al. Faecal microbiota transplant: a novel biological approach to extensively drug-resistant organism-related non-relapse mortality. Bone Marrow Transplant. 2017;52(10):1452–1454. doi:10.1038/bmt.2017.15128714946
   PubMed Web of Science ®Google Scholar
• Dolgin E. Fighting cancer with microbes. Nature. 2020;577(7792):S16–S18. doi:10.1038/d41586-020-00199-x31996833
   PubMed Web of Science ®Google Scholar
• Cavadas B, Camacho R, Ferreira JC, et al. Gastric Microbiome Diversities in Gastric Cancer Patients from Europe and Asia Mimic the Human Population Structure and Are Partly Driven by Microbiome Quantitative Trait Loci. Microorganisms. 2020;8:8. doi:10.3390/microorganisms8081196
   Web of Science ®Google Scholar
• Nayfach S, Shi ZJ, Seshadri R, et al. New insights from uncultivated genomes of the global human gut microbiome. Nature. 2019;568(7753):505–510. doi:10.1038/s41586-019-1058-x30867587
   PubMed Web of Science ®Google Scholar
• Hugon P, Lagier JC, Colson P, et al. Repertoire of human gut microbes. Microb Pathog. 2017;106:103–112. doi:10.1016/j.micpath.2016.06.02027317857
   PubMed Web of Science ®Google Scholar
• Sotoudegan F, Daniali M, Hassani S, et al. Reappraisal of probiotics’ safety in human. Food Chem Toxicol. 2019;129:22–29. doi:10.1016/j.fct.2019.04.03231009735
   PubMed Web of Science ®Google Scholar